Oxybuprocaine Olikla (Oxybuprocaine Hydrochloride)

Oxybuprocaine Hydrochloride, the active ingredient in Oxybuprocaine Olikla, is a local anesthetic presented as a unknown/unknown for ocular use. It provides surface anesthesia for diagnostic eye procedures and minor ocular interventions.

GNH USA supplies Oxybuprocaine Olikla as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxybuprocaine Olikla is an ophthalmic local anesthetic used to temporarily relieve discomfort during eye examinations and procedures. - Corneal abrasion examination: provides rapid surface anesthesia for patient comfort. - Intra‑ocular pressure measurement: facilitates accurate tonometry by numbing the cornea. - Minor ocular surgery: enables brief anesthesia for procedures such as foreign body removal. - Diagnostic fluorescein staining: reduces stinging when fluorescein dye is applied. - Contact lens fitting: eases discomfort during lens placement and removal.

Oxybuprocaine Olikla may cause transient ocular reactions following administration.

Common Side Effects: - Burning sensation: mild, short‑lived discomfort at the application site. - Stinging or itching: brief irritation after instillation. - Redness: mild conjunctival hyperaemia. - Tearing: increased lacrimation. - Blurred vision: temporary reduction in visual clarity. - Foreign‑body sensation: feeling of grit or particles.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or hives indicating hypersensitivity. - Corneal epithelial toxicity: persistent epithelial defect or ulceration. - Severe ocular inflammation: uveitis or keratitis requiring medical attention. - Vision loss: abrupt loss of vision, though extremely rare. - Systemic toxicity: dizziness or cardiac arrhythmia after excessive absorption.

When using Oxybuprocaine Olikla, follow standard ophthalmic safety practices. - Contraindication: avoid in patients with known hypersensitivity to oxybuprocaine or other ester‑type anesthetics. - Frequency: limit applications to the prescribed number to prevent corneal toxicity. - Contact lens wear: remove lenses before instillation and wait before reinserting. - Monitoring: observe for signs of allergic reaction or prolonged corneal opacity. - Store at room temperature: keep in the original container, protect from light and moisture.

Oxybuprocaine Olikla has a limited interaction profile, but certain agents may affect its safety or efficacy.

Major Interactions (Avoid): - Other ocular anesthetics: concurrent use can increase risk of corneal toxicity. - Preservative‑rich drops: may enhance irritation when combined.

Moderate Interactions (Monitor Closely): - Anticholinergic eye drops: may reduce tear production, heightening discomfort. - Systemic sodium channel blockers: theoretical additive effect on nerve conduction. - Topical steroids: may mask early signs of corneal injury. - Antihistamine eye drops: could alter ocular surface response. - Contact lens solutions containing preservatives: may increase irritation.